PALO ALTO, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ - News) announced today that Samuel Saks, M.D., the company’s Chief Executive Officer, will provide a corporate presentation at the UBS Life Sciences Conference in New York, NY on September 24, 2007 at 4:00 p.m. Eastern time.
